Nephrol Dial Transplant (2002) 17: 336-339
© 2002 European Renal Association-European Dialysis and Transplant Association
Cardiovascular calcification in end-stage renal disease
1 Department of Pediatrics and 2 Department of Medicine, UCLA School of Medicine, Los Angeles, CA, USA
Abstract
Cardiovascular diseases are common in patients with end-stage renal disease (ESRD) and cardiovascular morbidity and mortality among dialysis patients are substantially higher than in the general population. The reasons for this high incidence are multiple. They include traditional factors such as hypertension, diabetes, dyslipidaemia, sodium overload, and elevated homocysteine levels as well as disturbances of mineral metabolism, specifically abnormalities in phosphorus and calcium homeostasis. This review will describe the specific cardiovascular complications related to calcifications in ESRD, the implications of the abnormalities of mineral metabolism in its pathogenesis and the current imaging techniques available for the detection of cardiovascular calcifications. Excess of calcium load contributes to the development of cardiac calcifications; therefore, alternative strategies to diminish exogenous calcium load should be considered in patients with ESRD.
Keywords: cardiovascular calcification; end-stage renal disease
Notes
Correspondence and offprint requests to: Isidro B. Salusky, MD, Department of Pediatrics, UCLA Medical Center, A2-331, MDCC, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. Email: isalusky{at}mednet.ucla.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. A. Price, W. Si Chan, D. M. Jolson, and M. K. Williamson The Elastic Lamellae of Devitalized Arteries Calcify When Incubated in Serum: Evidence for a Serum Calcification Factor Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1079 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Houillier, M. Froissart, G. Maruani, and A. Blanchard What serum calcium can tell us and what it can't Nephrol. Dial. Transplant., January 1, 2006; 21(1): 29 - 32. [Full Text] [PDF] |
||||
![]() |
J. J. Schucker and K. E. Ward Hyperphosphatemia and phosphate binders Am. J. Health Syst. Pharm., November 15, 2005; 62(22): 2355 - 2361. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Behets, G. Dams, S. R. Vercauteren, S. J. Damment, R. Bouillon, M. E. De Broe, and P. C. D'Haese Does the Phosphate Binder Lanthanum Carbonate Affect Bone in Rats with Chronic Renal Failure? J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2219 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Drueke and D. A. McCarron Paricalcitol as Compared with Calcitriol in Patients Undergoing Hemodialysis N. Engl. J. Med., July 31, 2003; 349(5): 496 - 499. [Full Text] [PDF] |
||||




